SULLIVAN GREGORY M 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 25, 2021
Insider Transaction Report
Form 4
SULLIVAN GREGORY M
Chief Medical Officer
Transactions
- Award
Stock Option
2021-02-23+750,000→ 750,000 totalExercise: $1.22From: 2022-02-23Exp: 2031-02-23→ Common Stock (750,000 underlying) - Award
Stock Option
2021-02-23+750,000→ 750,000 totalExercise: $1.53From: 2022-02-23Exp: 2031-02-23→ Common Stock (750,000 underlying) - Award
Common Stock, $0.001 par value
2021-01-07$0.51/sh+41,322$21,074→ 62,727 total
Footnotes (3)
- [F1]The shares were purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan and are not required to be filed on a Form 4.
- [F2]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F3]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.